Tenofovir-based Prophylaxis

Tenofovir-Based Prophylaxis is a pharmacological intervention within the class of antiretroviral pre-exposure and post-exposure prophylactic regimens that employs tenofovir, a nucleotide reverse transcriptase inhibitor, as a foundational agent to prevent HIV acquisition through systemic suppression of viral replication in exposed individuals.

306

Publications

23.2K

Citations

2.3K

Authors

709

Institutions

Publications per year

2017–2026

155

Authors

2.3K

  1. PL
    Peter L. Anderson

    University of Colorado Anschutz Medical Campus, United States

    38 publications · 3.4K citations

    24

    h-index

  2. CW
    Craig W. Hendrix

    Johns Hopkins University, United States

    33 publications · 5.3K citations

    23

    h-index

  3. JM
    Jared M. Baeten

    University of Washington, United States

    26 publications · 4.9K citations

    21

    h-index

  4. MA
    Mark A. Marzinke

    Johns Hopkins University, United States

    29 publications · 1.3K citations

    21

    h-index

  5. CC
    Connie Celum

    University of Washington, United States

    20 publications · 4.7K citations

    18

    h-index

1–5 of 2.3K

Venues

  1. 24

    h-index

  2. Clinical Infectious Diseases

    CID · 27 publications · 1.6K citations

    20

    h-index

  3. AIDS

    25 publications · 1.5K citations

    19

    h-index

  4. The Journal of Infectious Diseases

    JID · 21 publications · 1.2K citations

    18

    h-index

  5. PLoS ONE

    19 publications · 1.1K citations

    17

    h-index

1–5